Effects of carprofen, meloxicam and deracoxib on platelet function in dogs

Veterinary Anaesthesia and Analgesia

Volumn 39, Issue 2, 2012, Pages 206-217

  Mullins, Kathleen B ^a   Thomason, John M ^a   Lunsford, Kari V ^a   Pinchuk, Lesya M ^a   Langston, Vernon C ^a   Wills, Robert W ^a   Mclaughlin, Ronald M ^a   J Mackin, Andrew ^a  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

Carprofen; Deracoxib; Meloxicam; Platelet function

Indexed keywords

EID: 84857402539     PISSN: 14672987     EISSN: 14672995     Source Type: Journal    
DOI: 10.1111/j.1467-2995.2011.00684.x     Document Type: Article

References (56)

1. Baltzer WI, McMichael MA, Ruaux CG et al. (2006) Measurement of urinary 11-dehydrothromboxane B2 excretion in dogs with gastric dilatation-volvulus. Am J Vet Res 67, 78-83.
2. Bergh MS, Budsberg SC (2005) The coxib NSAIDs: potential clinical and pharmacologic importance in veterinary medicine. J Vet Intern Med 19, 633-643.
3. Blaicher AM, Landsteiner HT, Zwerina J et al. (2004) Effect of non-selective, non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors on the PFA-100 closure time. Anaesthesia 59, 1100-1103.
4. Blois SL, Allen DG, Wood D et al. (2010) Effects of aspirin, carprofen, deracoxib, and meloxicam on platelet function and systemic prostaglandin concentrations in healthy dogs. Am J Vet Res 71, 349-358.
5. Brainard BM, Meredith CP, Callan MB et al. (2007) Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs. Am J Vet Res 68, 251-257.
6. Brideau C, Staden CV, Chan CC (2001) In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats. Am J Vet Res 62, 1755-1760.
7. Brunner E, Puri ML (2001) Nonparametric methods in factorial designs. Stat Pap 42, 1-52.
8. Callan MB, Giger U (2001) Assessment of a point-of-care instrument for identification of primary hemostatic disorders in dogs. Am J Vet Res 62, 652-658.
9. Catella F, FitzGerald GA (1987) Paired analysis of urinary thromboxane B2 metabolites in humans. Thromb Res 47, 647-656.
10. Catella F, Healy D, Lawson J et al. (1986) 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. Proc Natl Acad Sci U S A 83, 5861-5865.
11. Davies NM, Good RL, Roupe KA et al. (2004) Cyclooxygenase-3: axiom, dogma, anomaly, enigma, or splice error? - Not as easy as 1, 2, 3. J Pharm Pharm Sci 7, 217-226.
12. Dudley A, Thomason J, Grady J et al. (2011) Effects of low dose aspirin on canine platelet function. J Vet Int Med 25, 698-699 (abstract).
13. FitzGerald GA (1991) Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. Am J Cardiol 68, 11B-15B.
14. Funk CD, Funk LB, Kennedy ME (1991) Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J 5, 2304-2312.
15. Gaal T, Halmay D, Kocsis R et al. (2007) Evaluation of the effect of ketoprofen and carprofen on platelet function in dogs studied by PFA-100 point-of-care analyser. Acta Vet Hung 55, 287-294.
16. Grisneaux E, Pibarot P, Dupuis J et al. (1999) Comparison of ketoprofen and carprofen administered prior to orthopedic surgery for control of postoperative pain in dogs. J Am Vet Med Assoc 215, 1105-1110.
17. Harris RC, McKanna JA, Akai Y et al. (1994) Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 94, 2504-2510.
18. Hla T, Neilson K (1992) Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A 89, 7384-7388.
19. Jones CJ, Budsberg SC (2000) Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and cats. J Am Vet Med Assoc 217, 721-729.
20. Jones DA, Carlton DP, McIntyre TM et al. (1993) Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 268, 9049-9054.
21. Jones CJ, Streppa HK, Harmon BG et al. (2002) In vivo effects of meloxicam and aspirin on blood, gastric mucosal, and synovial fluid prostanoid synthesis in dogs. Am J Vet Res 63, 1527-1531.
22. Kaufmann WE, Worley PF, Pegg J et al. (1996) COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci U S A 93, 2317-2321.
23. Kay-Mugford PA, Benn SJ, LaMarre J et al. (2000a) Cyclooxygenase expression in canine platelets and Madin-Darby canine kidney cells. Am J Vet Res 61, 1512-1516.
24. Kay-Mugford PA, Benn SJ, LaMarre J et al. (2000b) In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs. Am J Vet Res 61, 802-810.
25. Kitchen L, Erichson RB, Sideropoulos H (1982) Effect of drug-induced platelet dysfunction on surgical bleeding. Am J Surg 143, 215-217.
26. Kundu SK, Heilmann EJ, Sio R et al. (1995) Description of an in vitro platelet function analyzer - PFA-100. Semin Thromb Hemost 21(Suppl. 2), 106-112.
27. Lafuente MP, Franch J, Durall I et al. (2005) Comparison between meloxicam and transdermally administered fentanyl for treatment of postoperative pain in dogs undergoing osteotomy of the tibia and fibula and placement of a uniplanar external distraction device. J Am Vet Med Assoc 227, 1768-1774.
28. Leese PT, Recker DP, Kent JD (2003) The COX-2 selective inhibitor, valdecoxib, does not impair platelet function in the elderly: results of a randomized controlled trial. J Clin Pharmacol 43, 504-513.
29. Lemke KA, Runyon CL, Horney BS (2002) Effects of preoperative administration of ketoprofen on anesthetic requirements and signs of postoperative pain in dogs undergoing elective ovariohysterectomy. J Am Vet Med Assoc 221, 1268-1275.
30. Li W, Lian YY, Yue WJ et al. (2009) Experimental study of COX-2 selective and traditional non-steroidal anti-inflammatory drugs in total hip replacement. J Int Med Res 37, 472-478.
31. Lipscomb VJ, AliAbadi FS, Lees P et al. (2002) Clinical efficacy and pharmacokinetics of carprofen in the treatment of dogs with osteoarthritis. Vet Rec 150, 684-689.
32. Luna SP, Basilio AC, Steagall PV et al. (2007) Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs. Am J Vet Res 68, 258-264.
33. Mathews KA, Pettifer G, Foster R et al. (2001) Safety and efficacy of preoperative administration of meloxicam, compared with that of ketoprofen and butorphanol in dogs undergoing abdominal surgery. Am J Vet Res 62, 882-888.
34. Meen Ø, Brosstad F, Khiabani H et al. (2008) No case of COX-1-related aspirin resistance found in 289 patients with symptoms of stable CHD remitted for coronary angiography. Scand J Clin Lab Invest 68, 185-191.
35. Mischke R, Keidel A (2003) Influence of platelet count, acetylsalicylic acid, von Willebrand's disease, coagulopathies, and haematocrit on results obtained using a platelet function analyser in dogs. Vet J 165, 43-52.
36. Møiniche S, Rømsing J, Dahl JB et al. (2003) Nonsteroidal antiinflammatory drugs and the risk of operative site bleeding after tonsillectomy: a quantitative systematic review. Anesth Analg 96, 68-77.
37. Moncada S, Gryglewski R, Bunting S et al. (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263, 663-665.
38. Montoya L, Ambros L, Kreil V et al. (2004) A pharmacokinetic comparison of meloxicam and ketoprofen following oral administration to healthy dogs. Vet Res Commun 28, 415-428.
39. Ng KF, Lawmin JC, Tsang SF et al. (2009) Value of a single preoperative PFA-100 measurement in assessing the risk of bleeding in patients taking cyclooxygenase inhibitors and undergoing total knee replacement. Br J Anaesth 102, 779-784.
40. Nielsen LA, Zois NE, Pedersen HD et al. (2007) Platelet function in dogs: breed differences and effect of acetylsalicylic acid administration. Vet Clin Pathol 36, 267-273.
41. Palmer JD, Sparrow OC, Iannotti F (1994) Postoperative hematoma: a 5-year survey and identification of avoidable risk factors. Neurosurgery 35, 1061-1065.
42. Patrignani P, Sciulli MG, Manarini S et al. (1999) COX-2 is not involved in thromboxane biosynthesis by activated human platelets. J Physiol Pharmacol 50, 661-667.
43. Perneby C, Granstrom E, Beck O et al. (1999) Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS. Thromb Res 96, 427-436.
44. Pibarot P, Dupuis J, Grisneaux E (1997) Comparison of ketoprofen, oxymorphone hydrochloride, and butorphanol in the treatment of postoperative pain in dogs. J Am Vet Med Assoc 211, 438-444.
45. Ricketts AP, Lundy KM, Seibel SB (1998) Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs. Am J Vet Res 59, 1441-1446.
46. Roberts LJ, Sweetman BJ, Oates JA (1981) Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites. J Biol Chem 256, 8384-8393.
47. Sessions JK, Reynolds LR, Budsberg SC (2005) In vivo effects of carprofen, deracoxib, and etodolac on prostanoid production in blood, gastric mucosa, and synovial fluid in dogs with chronic osteoarthritis. Am J Vet Res 66, 812-817.
48. Shah DA, Madden LV (2004) Nonparametric analysis of ordinal data in designed factorial experiments. Phytopathology 94, 33-43.
49. Smith WL, Langenbach R (2001) Why there are two cyclooxygenase isozymes. J Clin Invest 107, 1491-1495.
50. Smith CJ, Morrow JD, Roberts LJ et al. (1993) Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1). Biochem Biophys Res Commun 192, 787-793.
51. Smith CJ, Morrow JD, Roberts LJ et al. (1997) Induction of prostaglandin endoperoxide synthase-1 (COX-1) in a human promonocytic cell line by treatment with the differentiating agent TPA. Adv Exp Med Biol 400A, 99-106.
52. Streppa HK, Jones CJ, Budsberg SC (2002) Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood. Am J Vet Res 63, 91-94.
53. Thomason J, Mackin A, Stokes J et al. (2010) Effects of aspirin on canine platelet cyclooxygenase expression. J Vet Intern Med 24, 681-682 (abstract).
54. Topper JN, Cai J, Falb D et al. (1996) Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci USA 93, 10417-10422.
55. Weber A, Przytulski B, Schumacher M et al. (2002) Flow cytometry analysis of platelet cyclooxygenase-2 expression: induction of platelet cyclooxygenase-2 in patients undergoing coronary artery bypass grafting. Br J Haematol 117, 424-426.
56. Wilson JE, Chandrasekharan NV, Westover KD et al. (2004) Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs. Am J Vet Res 65, 810-818.